AAAAAA

   
Results: 1-7 |
Results: 7
EXPLICIT GUIDANCE IS REQUIRE ON VALID EXEMPTIONS FOR NEED FOR ETHICALREVIEW
Authors: WOODCOCK T NORMAN J
Citation: T. Woodcock et J. Norman, EXPLICIT GUIDANCE IS REQUIRE ON VALID EXEMPTIONS FOR NEED FOR ETHICALREVIEW, BMJ. British medical journal, 315(7102), 1997, pp. 250-250
INFORMED CONSENT FOR RESEARCH PURPOSES IN INTENSIVE-CARE PATIENTS IN EUROPE .2. AN OFFICIAL STATEMENT OF THE EUROPEAN-SOCIETY OF INTENSIVE-CARE MEDICINE
Authors: LEMAIRE F BLANCH L COHEN SL SPRUNG C ABIZANDA R ARMAGANIDIS A BLIN F CONTI G DICK W DRAGSTED L EKLUND J KAHN RJ LEGALL JR MATAMIS D MUTZ N NET A CARDOSO AP RUYTER S SCHUSTER HP SUTER PM TAKALA J THIJS LG VINCENT JL WOODCOCK T
Citation: F. Lemaire et al., INFORMED CONSENT FOR RESEARCH PURPOSES IN INTENSIVE-CARE PATIENTS IN EUROPE .2. AN OFFICIAL STATEMENT OF THE EUROPEAN-SOCIETY OF INTENSIVE-CARE MEDICINE, Intensive care medicine, 23(4), 1997, pp. 435-439
INFORMED CONSENT FOR RESEARCH PURPOSES IN INTENSIVE-CARE PATIENTS IN EUROPE .1. AN OFFICIAL STATEMENT OF THE EUROPEAN-SOCIETY OF INTENSIVE-CARE MEDICINE
Authors: LEMAIRE F BLANCH L COHEN SL SPRUNG C ABIZANDA R ARMAGANIDIS A BLIN F CONTI G DICK W DRAGSTED L EKLUND J KAHN RJ LEGALL JR MATAMIS D MUTZ N NET A CARDOSO AP RUYTER S SCHUSTER HP SUTER PM TAKALA J THIJS LG VINCENT JL WOODCOCK T
Citation: F. Lemaire et al., INFORMED CONSENT FOR RESEARCH PURPOSES IN INTENSIVE-CARE PATIENTS IN EUROPE .1. AN OFFICIAL STATEMENT OF THE EUROPEAN-SOCIETY OF INTENSIVE-CARE MEDICINE, Intensive care medicine, 23(3), 1997, pp. 338-341
VENOVENOUS HEMODIAFILTRATION IN MENINGOCOCCAL SEPTICEMIA
Authors: CONNETT G WALDRON M WOODCOCK T
Citation: G. Connett et al., VENOVENOUS HEMODIAFILTRATION IN MENINGOCOCCAL SEPTICEMIA, Lancet, 347(9001), 1996, pp. 611-611
CLINICAL SKILLS STILL PROVOKE DEBATE - CLINICAL SKILLS ARE COMPLEMENTED BY TECHNOLOGY
Authors: WOODCOCK T
Citation: T. Woodcock, CLINICAL SKILLS STILL PROVOKE DEBATE - CLINICAL SKILLS ARE COMPLEMENTED BY TECHNOLOGY, BMJ. British medical journal, 311(7005), 1995, pp. 627-627
PHASE-II TRIAL OF 5-FLUOROURACIL, FOLINIC ACID, AND N,N-1,N-11-TRIETHYLENETHIOPHOSPHORAMIDE (THIOTEPA) IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: JOSEPH G HAMM J MORRIS K SEEGER J BLUMENREICH M HADLEY T HENDLER F WOODCOCK T
Citation: G. Joseph et al., PHASE-II TRIAL OF 5-FLUOROURACIL, FOLINIC ACID, AND N,N-1,N-11-TRIETHYLENETHIOPHOSPHORAMIDE (THIOTEPA) IN PATIENTS WITH ADVANCED BREAST-CANCER, American journal of clinical oncology, 18(5), 1995, pp. 385-388
IF DURING ATTEMPTED RESUSCITATION OF A PATIENT WITH AN ASYSTOLIC ARREST NEITHER INTRAVENOUS ACCESS NOR INTUBATION WERE ACHIEVED SHOULD INTRACARDIAC ADRENALINE BE GIVEN
Authors: WOODCOCK T
Citation: T. Woodcock, IF DURING ATTEMPTED RESUSCITATION OF A PATIENT WITH AN ASYSTOLIC ARREST NEITHER INTRAVENOUS ACCESS NOR INTUBATION WERE ACHIEVED SHOULD INTRACARDIAC ADRENALINE BE GIVEN, BMJ. British medical journal, 308(6938), 1994, pp. 1212-1212
Risultati: 1-7 |